Takeda Pharmaceutical Co. Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Takeda Pharmaceutical Co. Ltd.
Japan Eyes Cutting Reimbursement For COVID-19 Drugs
Japan will end full reimbursement coverage for COVID-19 therapeutic drugs from October, after downgrading the status of the virus to the same level as seasonal flu in early May. As authorities discuss the possible coverage reduction, a larger than usual price cut may also be applied to Shionogi's oral COVID antiviral Xocova.
Lilly Unlucky? Lilly Leads Big Pharma In US FDA Complete Response Letters
Clinical concerns outweigh quality issues in big pharma CRLs, a Pink Sheet analysis finds, making mirikizumab – the fourth new product candidate sponsored by Lilly to receive a CRL since 2021 – even more of an outlier: it was turned back by FDA because of manufacturing concerns.
Fostering a Culture of Innovation, From Evolutionary To Revolutionary
Innovation is a key to long-term success for biopharma companies, but building the right climate to foster creative problem-solving is challenging. Questioning assumptions and constraining the target of innovation can propel a company forward.
Japan Readies One-Off Price Cuts For Big Sellers
Japanese regulatory authorities have announced a set of additional reimbursement price cuts for selected products in August, under which Novartis’s heart failure drug Entresto will see its price slashed by 15%. A batch of other newly approved drugs has also been priced.
- Other Names / Subsidiaries
- Adaptate Biotherapeutics Ltd
- Altos Therapeutics LLC
- AR Scientific, Inc. (URL)
- ARIAD Pharmaceuticals, Inc.
- Bradley Pharmaceuticals, Inc
- Cellerix SA
- Cerevance, Envoy Therapeutics, Inc.
- Chordia Therapeutics
- ChromaJean, Inc.
- GammaDelta Therapeutics
- IDM Pharma
- Intellikine, Inc.
- Inviragen, Inc.
- LigoCyte Pharmaceuticals, Inc.
- Maverick Therapeutics, Inc.
- Millennium Pharmaceuticals, Inc.
- Mutual Pharmaceutical Company, Inc. (URL)
- Nihon Pharmaceutical Co., Ltd
- Nycomed Pharma AS
- Pharmaceutical Holdings Corporation (URL)
- PvP Biologics, Inc.
- sanaplasma AG
- Syrrx, Inc.
- TAP Pharmaceutical Products, Inc.
- Teva Takeda Pharma Ltd.
- Shire Pharmaceuticals Group PLC (SHPG)
- Teva Takeda Yakuhin Ltd.
- TiGenix NV
- URL Pharma, Inc. Advanced BioHealing, Inc. (renamed Shire Regenerative Medicine)
- AesRX LLC
- Baxalta Incorporated
- BIKAM Pharmaceuticals Inc.
- Chatham Therapeutics
- Dyax Corp.
- FerroKin BioSciences, Inc.
- Fibrotech Therapeutics
- Foresight Biotherapeutics Inc.
- Gambro AB
- Jerini AG
- Lotus Tissue Repair
- Lumena Pharmaceuticals
- Meritage Pharma, Inc.
- Movetis NV
- New Pervasis Therapeutics, Inc.
- NPS Pharmaceuticals, Inc.
- Premacure AB
- Prism Pharmaceuticals, Inc.
- River Pharmaceuticals
- Roberts Pharmaceutical Corporation
- SARcode Corporation
- SuppreMol GmbH
- Synovis Life Technologies, Inc.
- Transkaryotic Therapies, Inc.
- ViroPharma Inc.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.